Cardiac stem cells and myocardial disease

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 4, 2008, Pages 505-513

  Kajstura, Jan ^a,b   Urbanek, Konrad ^a,b   Rota, Marcello ^a,b   Bearzi, Claudia ^a,b   Hosoda, Toru ^a,b   Bolli, Roberto ^a,b   Anversa, Piero ^a,b   Leri, Annarosa ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Cardiac aging; Diabetic cardiomyopathy; Heart failure; Stem cells

Indexed keywords

AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIUM CELL; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MULTIPOTENT STEM CELL; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALS; HEART DISEASES; HUMANS; MULTIPOTENT STEM CELLS; MYOCARDIUM; STEM CELL TRANSPLANTATION;

EID: 54149095610     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.05.025     Document Type: Review

References (83)

1. Jones P.H., and Watt F.M. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73 (1993) 713-724
2. Watt F.M., and Hogan B.L.M. Out of Eden: stem cells and their niches. Science 287 (2000) 1427-1438
3. Taylor G., Lehrer M.S., Jensen P.J., Sun T.T., and Lavker R.M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102 (2000) 451-461
4. Wright N.A. Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int. J. Exp. Pathol. 81 (2000) 117-143
5. Shinohara T., Orwig K.E., Avarbock M.R., and Brinster R.L. Remodeling of the postnatal mouse testis is accompanied by dramatic changes in stem cell number and niche accessibility. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6186-6191
6. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
7. Lie D.C., Song H., Colamarino S.A., Ming G.L., and Gage F.H. Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 399-421
8. Moore K.A., and Lemischka I.R. Stem cells and their niches. Science 311 (2006) 1880-1885
9. Yin T., and Li L. The stem cell niches in bone. J. Clin. Invest. 116 (2006) 1195-1201
10. Flickinger R.A. Hierarchical differentiation of multipotent progenitor cells. Bioessays 21 (1999) 333-338
11. Quesenberry P.J., Colvin G.A., Abedi M., Dooner G., Dooner M., Aliotta J., et al. The stem cell continuum. Ann. N.Y. Acad. Sci. 1044 (2005) 228-235
12. Gotz M., and Huttner W.B. The cell biology of neurogenesis. Nat. Rev. Mol. Cell. Biol. 6 (2005) 777-788
13. Crosnier C., Stamataki D., and Lewis J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7 (2006) 349-359
14. Watt F.M. Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 353 (1998) 831-837
15. Kaur P. Interfollicular epidermal stem cells: identification, challenges, potential. J. Invest. Dermatol. 126 (2006) 1450-1458
16. Diaz-Flores Jr. L., Madrid J.F., Gutierrez R., Varela H., Valladares F., Alvarez-Arguelles H., et al. Adult stem and transit-amplifying cell location. Histol. Histopathol. 21 (2006) 995-1027
17. Beltrami C.A., Finato N., Rocco M., Feruglio G.A., Puricelli C., Cigola E., et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89 (1994) 151-163
18. Anversa P., Capasso J.M., Olivetti G., and Sonnenblick E.H. Cellular basis of ventricular remodeling in hypertensive cardiomyopathy. Am. J. Hypertens 5 (1992) 758-770
19. Anversa P., Palackal T., Sonnenblick E.H., Olivetti G., and Capasso J.M. Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart. J. Clin. Invest. 85 (1990) 994-997
20. Beltrami C.A., Finato N., Rocco M., Feruglio G.A., Puricelli C., Cigola E., et al. The cellular basis of dilated cardiomyopathy in humans. J. Mol. Cell. Cardiol. 27 (1995) 291-305
21. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8692-8697
22. Olivetti G., Melissari M., Balbi T., Quaini F., Sonnenblick E.H., and Anversa P. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J. Am. Coll. Cardiol. 24 (1994) 140-149
23. Urbanek K., Quaini F., Tasca G., Torella D., Castaldo C., Nadal-Ginard B., et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10440-10445
24. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344 (2001) 1750-1757
25. Jessup M., and Brozena S. Heart failure. N. Engl. J. Med. 348 (2003) 2007-2018
26. Aurigemma G.P., and Gaasch W.H. Clinical practice. Diastolic heart failure. N. Engl. J. Med. 351 (2004) 1097-1105
27. Leri A., Kajstura J., and Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev. 85 (2005) 1373-1416
28. Anversa P., Leri A., and Kajstura J. Cardiac regeneration. J. Am. Coll. Cardiol. 47 (2006) 1769-1776
29. Opie L.H., Commerford P.J., Gersh B.J., and Pfeffer M.A. Controversies in ventricular remodelling. Lancet 367 (2006) 356-367
30. Bache R.J. Effects of hypertrophy on the coronary circulation. Prog. Cardiovasc. Dis. 30 (1988) 403-440
31. Harrison D.G., Barnes D.H., Hiratzka L.F., Eastham C.L., Kerber R.E., and Marcus M.L. The effect of cardiac hypertrophy on the coronary collateral circulation. Circulation 71 (1985) 1135-1145
32. Anversa P., and Olivetti G. Cellular basis of physiological and pathological myocardial growth. Handbook of Physiology, Section 2: the Cardiovascular System: the Heart, Volume 1 (2002), Oxford University Press, New York 75-144
33. Sussman M.A., and Anversa P. Myocardial aging and senescence: where have the stem cells gone?. Annu. Rev. Physiol. 66 (2004) 29-48
34. Anversa P., Rota M., Urbanek K., Hosoda T., Sonnenblick E.H., Leri A., Kajstura J., and Bolli R. Myocardial aging-a stem cell problem. Basic Res. Cardiol. 100 (2005) 482-493
35. Anversa P., Kajstura J., Leri A., and Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113 (2006) 1451-1463
36. Chimenti C., Kajstura J., Torella D., Urbanek K., Heleniak H., Colussi C., et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 93 (2003) 604-613
37. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., et al. Myocardial cell death in human diabetes. Circ. Res. 87 (2000) 1123-1132
38. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355 (2006) 251-259
39. Devereux R.B., Roman M.J., Paranicas M., O'Grady M.J., Lee E.T., Welty T.K., et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101 (2000) 2271-2276
40. Torella D., Rota M., Nurzynska D., Musso E., Monsen A., Shiraishi I., et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94 (2004) 514-524
41. Kajstura J., Rota M., Urbanek K., Hosoda T., Bearzi C., Anversa P., et al. The telomere-telomerase axis and the heart. Antioxid. Redox. Signal. 8 (2006) 2125-2141
42. Lopez L.R., Schocket A.L., Stanford R.E., Claman H.N., and Kohler P.F. Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J. Rheumatol. 7 (1980) 677-684
43. Saegusa M., Takano Y., and Okudaira M. Human hepatic infarction: histopathological and postmortem angiological studies. Liver 13 (1993) 239-245
44. Watanabe K., Abe H., Mishima T., Ogura G., and Suzuki T. Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schonlein purpura and polyarteritis nodosa. Pathol. Int. 53 (2003) 569-573
45. Leong F.T., and Freeman L.J. Acute renal infarction. J.R. Soc. Med. 98 (2005) 121-122
46. Maude G.H. Bone marrow infarction in sickle cell anemia. Blood 63 (1984) 243
47. Dang N.C., Johnson C., Eslami-Farsani M., and Haywood L.J. Bone marrow embolism in sickle cell disease: a review. Am. J. Hematol. 79 (2005) 61-67
48. Callaghan M.J., Ceradini D.J., and Gurtner G.C. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid. Redox. Signal. 7 (2005) 1476-1482
49. Rossi D.J., Bryder D., Zahn J.M., Ahlenius H., Sonu R., Wagers A.J., et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9194-9199
50. Yao E.H., Yu Y., and Fukuda N. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr. Pharm. Biotechnol. 7 (2006) 101-108
51. Boudina S., and Abel E.D. Diabetic cardiomyopathy revisited. Circulation 115 (2007) 3213-3223
52. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192 (2002) 1-15
53. Burch P., and Heintz N. Redox regulation of cell cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid. Redox. Signal. 7 (2005) 741-751
54. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes. 50 (2001) 2363-2375
55. Kajstura J., Fiordaliso F., Andreoli A.M., Li B., Chimenti S., Medow M.S., et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50 (2001) 1414-1424
56. Rota M., LeCapitaine N., Hosoda T., Boni A., De Angelis A., Padin-Iruegas M.E., et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99 (2006) 42-52
57. Iiyama M., Kakihana K., Kurosu T., and Miura O. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Cell. Signal. 18 (2006) 174-182
58. Cakir Y., and Ballinger S.W. Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK. Antioxid. Redox. Signal. 7 (2005) 726-740
59. Gibson B.W. The human mitochondrial proteome: oxidative stress, protein modifications and oxidative phosphorylation. Int. J. Biochem. Cell. Biol. 37 (2005) 927-934
60. Shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402 (1999) 309-313
61. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122 (2005) 221-233
62. SHC promotes apoptosis and antagonizes mitogenic signaling in T cells. Mol. Cell. Biol. 24 (2004) 1747-1757
63. shc splicing isoforms on the EGF receptor-MAP kinase-fos signaling pathway. EMBO J. 16 (1997) 706-716
64. Lotti L.V., Lanfrancone L., Migliaccio E., Zompetta C., Pelicci G., Salcini A.E., Falini B., Pelicci P.G., and Torrisi M.R. Shc proteins are localized on endoplasmic reticulum membranes and are redistributed after tyrosine kinase receptor activation. Mol. Cell. Biol. 16 (1996) 1946-1954
65. Chen X., Wilson R.M., Kubo H., Berretta R.M., Harris D.M., Zhang X., et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ. Res. 100 (2007) 536-544
66. Rota M., Hosoda T., De Angelis A., Arcarese M.L., Esposito G., Rizzi R., et al. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ. Res. 101 (2007) 387-399
67. Nadal-Ginard B., Kajstura J., Leri A., and Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92 (2003) 139-150
68. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-766
69. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA. 100 (2003) 12313-12318
70. Martin C.M., Meeson A.P., Robertson S.M., Hawke T.J., Richardson J.A., Bates S., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265 (2004) 262-275
71. Pfister O., Mouquet F., Jain M., Summer R., Helmes M., Fine A., et al. CD31- but not CD31+ cardiac side populations cells exhibit functional cardiomyogenic differentiation. Circ. Res. 97 (2005) 52-61
72. Rosenblatt-Velin N., Lepore M.G., Cartoni C., Beermann F., and Pedrazzini T. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J. Clin. Invest. 115 (2005) 1724-1733
73. Tomita Y., Matsumura K., Wakamatsu Y., Matsuzaki Y., Shibuya I., Kawaguchi H., et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J. Cell. Biol. 170 (2005) 1135-1146
74. Oyama T., Nagai T., Wada H., Naito A.T., Matsuura K., Iwanaga K., et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J. Cell. Biol. 176 (2007) 329-341
75. Urbanek K., Cesselli D., Rota M., Nascimbene A., De Angelis A., Hosoda T., et al. Stem cell niches in the adult mouse heart. Proc. Natl. Acad. Sci. USA. 103 (2006) 9226-9231
76. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 73 (1993) 413-467
77. Wei J.Y. Age and the cardiovascular system. N. Engl. J. Med. 237 (1992) 1735-1739
78. Martin G.M., and Oshima J. Lessons from human progeroid syndromes. Nature 408 (2000) 263-266
79. Postiglione A., Soricelli A., Covelli E.M., Iazzetta N., Ruocco A., Milan G., et al. Premature aging in Werner's syndrome spares the central nervous system. Neurobiol. Aging 17 (1996) 325-330
80. Guerra S., Leri A., Wang X., Finato N., Di Loreto C., Beltrami C.A., et al. Myocyte death in the failing human heart is gender dependent. Circ. Res. 85 (1999) 856-866
81. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. USA. 102 (2005) 8966-8971
82. Urbanek K., Rota M., Cascapera S., Bearzi C., Nascimbene A., De Angelis A., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97 (2005) 663-673
83. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., et al. Human cardiac stem cells. Proc. Natl. Acad. Sci. USA. 104 (2007) 14068-14073